SCHEMBL2551564

SCHEMBL2551564

CCN1CCC(CS(=O)(=O)c2ccc(CNC3CCCC3)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.45
FABP6 P51161 1/20 0.44
POLB P06746 1/20 0.43
OPRM1 P35372 2/20 0.42
OPRK1 P41145 2/20 0.42
ACHE P22303 3/20 0.41
BACE1 P56817 3/20 0.41
HDAC1 Q13547 1/20 0.40
KCNH2 Q12809 1/20 0.40
BCHE P06276 2/20 0.40
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
EBP Q15125 1/20 0.39
DHCR7 Q9UBM7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2548181 0.83 HRH3 (0.43) HRH3FABP6POLBOPRM1OPRK1
SCHEMBL7716923 0.83 SMN1; SMN2 (0.54) HRH3FABP6POLBKCNH2ALDH1A1
SCHEMBL2547933 0.79 KDM4E (0.48) HRH3FABP6POLBACHEBACE1
SCHEMBL2555109 0.79 KDM4E (0.48) HRH3FABP6POLBACHEBACE1
SCHEMBL7716908 0.79 KDM4E (0.48) HRH3FABP6POLBACHEBACE1
Hydrochloric Acid SCHEMBL2552428 0.78 KDM4E (0.47) HRH3FABP6POLBACHEBACE1
Hydrochloric Acid SCHEMBL2552429 0.78 KDM4E (0.47) HRH3FABP6POLBACHEBACE1
SCHEMBL2555154 0.76 KDM4E (0.48) HRH3FABP6POLBOPRM1OPRK1
SCHEMBL2553884 0.76 HTR2A (0.50) HRH3FABP6OPRM1OPRK1ALDH1A1
SCHEMBL13861355 0.75 PSIP1 (0.50) HRH3FABP6POLBOPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011121309-A1 PHENYL SULFONYL DERIVATIVES AND THEIR USE AS HISTAMINE H3 ANTAGONISTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-10-06 WO disclosed
WO-2011121309-A1 PHENYL SULFONYL DERIVATIVES AND THEIR USE AS HISTAMINE H3 ANTAGONISTS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-10-06 WO disclosed